Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

This study has been completed.
Sponsor:
Information provided by:
FDA Office of Orphan Products Development
ClinicalTrials.gov Identifier:
NCT00004409
First received: October 18, 1999
Last updated: March 24, 2015
Last verified: May 2001
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2004
  Estimated Primary Completion Date: No date given